Share Name |
Share Symbol |
Market |
Type |
Share ISIN |
Share Description |
Crystal Amber Fund Limited |
LSE:CRS |
London |
Ordinary Share |
GG00B1Z2SL48 |
ORD 1P |
|
Price Change |
% Change |
Share Price |
Bid Price |
Offer Price |
High Price |
Low Price |
Open Price |
Shares Traded |
Last Trade |
|
0.00 |
0.0% |
105.00 |
104.00 |
106.00 |
105.00 |
105.00 |
105.00 |
13,669 |
08:00:00 |
Industry Sector |
Turnover (m) |
Profit (m) |
EPS - Basic |
PE Ratio |
Market Cap (m) |
Equity Investment Instruments |
3.3 |
0.3 |
0.4 |
276.3 |
93 |
Crystal Amber Share Discussion Threads

Showing 426 to 449 of 625 messages
Date | Subject | Author | Discuss |
---|
14/11/2019 12:09 | Fair analysis, but want it lower first! Wondered about buying CRS as a discounted way into ALM, but doesn't hold enough so bought ALM instead :) |  spectoacc | |
14/11/2019 11:58 | IMO this is weak today because GI Dynamics has sold off significantly on the ASX overnight - although I can't find any specific news for this. Could be a failed clinical trial or a more general regulation change in the US related to obesity treatments that hasn't made the major news channels yet.
The bull case is that CRS is now on a discount to NAV of around 29% at current prices, or 19% if you are cautious and write down GID to zero, and historically it has traded between 15% and 5% discount.
You obviously have to believe that the larger holdings like HUR, NTG, EQLS are not massively overvalued at current prices - if you think they are overvalued then this will never be investable - however, a 29% discount buys a lot of leeway if you don't like one or two investments that CRS holds.
Most investors tend to act against their best interests - they buy into funds when they have had good recent performance narrowing discounts, and sell when funds have weak recent performance, increasing discounts. In reality, no fund manager goes from hero to villain and back to hero in one or two years and its just a mix of luck and skill, combined with market mean reversion, that causes these cycles. Those who can act counter-cyclically earn both the fund return and the narrowing discount, those who follow the herd pay the market twice. |  dangersimpson2 | |
14/11/2019 11:29 | Drifting off a bit now. Slightly surprising it took so long personally. Anyone think there's a bull case here? Would be(genuinely) interesting to hear it. |  cwa1 | |
07/11/2019 23:02 | RB has put his own money into what is by all accounts a shell.He has a 29% stake and is looking to make “ real” money for himself.....The company is Ultimate Sports Group ( usg) |  ltinvestor | |
07/11/2019 22:53 | So much for activism. Hard to breathe life into dying horses. |  p1nkfish | |
07/11/2019 14:43 | Equals Group ( formerly FairFx). Another recent poor performer in the Crystal Amber stable.
July 130p. Today 85p.
ALL IMO. DYOR.
QP |  quepassa | |
07/11/2019 10:10 | Judging by the size of the vote against at ALM yesterday, suspect that will have been CRS. If so, they're largely on their own, and haven't done anything (publicly) despite their previous comments. |  spectoacc | |
05/11/2019 21:50 | DLAR may tumble to 50p in my opinion.
all imo. dyor.
qp |  quepassa | |
05/11/2019 21:36 | They were right but wrong. |  p1nkfish | |
05/11/2019 20:48 | Those DLAR comments in the October NAV really don't do CRS any credit.
"..The Fund continues to believe that De La Rue enjoys both strong competitive positions in high return businesses and a range of attractive growth opportunities. The company's total order book grew by 20% over the last financial year and its security features revenue increased by 38%."
"There is early evidence that the new Chief Executive will adopt a focused and sensible approach targeted at rebuilding the value of De La Rue's banknote business"
"De La Rue also has obvious strategic value"
Well, a t/o may yet come along, but doubt it'll be enough to bail out CRS's investment.
Rule no.1 - don't lose money. Rule no.2 (you know it). |  spectoacc | |
30/10/2019 08:24 | it likely will in my view......
all imo. dyor.
qp |  quepassa | |
30/10/2019 08:14 | Slightly surprised the share price hasn't backed off at least a little bit so far, but that's markets for you. |  cwa1 | |
30/10/2019 08:08 | de la rue down a gob-smacking c25% at open today.
a big hit for crs.
wow..
all imo. dyor.
qp |  quepassa | |
30/10/2019 08:06 | Yes, the DLAR announcement looks a bit of a sickener, that's not going to go down well(albeit going down for sure!) |  cwa1 | |
30/10/2019 07:44 | heading down resolutely.
graph looking bad.
some of their big investments have had poor performance recently.
pretty dire results from De La Rue today - one of their big holdings.
it wouldn't surprise me personally if discount-to-nav widens further as underlying performance of fund does not inspire confidence in my view.
all imo. dyor.
qp |  quepassa | |
02/10/2019 18:08 | The end September NAV will by my calculation show another drop to about 214p thanks to a 20% fall in EQLS and a small drop in HUR. Currently CRS is trading at a 10% discount to NAV which I suppose is inexpensive if you like the underlying portfolio. |  kinwah | |
13/9/2019 08:03 | The write-up on DeLaRue in the results is interesting. Shines a light on the management. Worth a read. |  p1nkfish | |
04/9/2019 23:00 | Ineffectual. |  p1nkfish | |
28/8/2019 18:12 | Would very much tend to agree. Hardly achieving much. |  p1nkfish | |
26/7/2019 11:32 | i understand what their modus operandi is and what an activist investor does/means/intends and the sort of situations they like to invest in. i follow them.
i judge the impact they have on their target investments and i measure them on their success rate.
certainly their investments and impact in and on dlar and cnks, for example, have in my opinion been poorly timed, significantly loss-making for them ( and by extension shareholders) and have not yet - even after several years- helped improve the fortunes of either target company.
my own personal opinion of CRS is that they are somewhat lame and lacking weight, reach and punch as an activist investor.
good luck all.
all imo. dyor.
qp |  quepassa | |
26/7/2019 11:06 | the process is largely to invest in contentious areas - agitate for change and then sell when everyone else thinks it is investable. he has a reasonable hit rate and at least puts the pedal to the metal to exact change and call out bad governance. he alone it appears is putting heat on dlar. i find his approach refreshing and in the interests of minority shareholders in a world of otherwise institutional apathy. |  edwardt | |
25/7/2019 14:44 | Yes, you make good points and allude to the NAV impact but also the intangible costs to reputation and to investor sentiment by association with DLAR, CNKS and Woodford are not to be underestimated.
ALL IMO. DYOR.
QP |  quepassa | |
25/7/2019 11:06 | I don't like the Woodford link, I've been saying that particular emperor had no clothes for years. Re: DLAR the SFO kind of backs up what RB has been saying though: that the company has been seriously mismanaged by the current management. CRS was clearly too early buying into that story and almost certainly underestimated the challenge of turning things around!
You have to hold it all in perspective though, as a listed company CRS cannot control who buys their shares, and the drop in DLAR over the last month has only cost them 5p of NAV. If both DLAR and CNKS go to zero this would still be on a 13% discount to NAV. The overhang from the Woodford sale has depressed the price far below the levels that this typically has traded at and therein lies opportunity for more patient investors. |  dangersimpson2 | |
25/7/2019 08:53 | Fact Woodford was heavily invested is also worth thinking about. |  p1nkfish | |